ICN is led by a Steering Board consisting of representatives of all ten core members. The Steering Board is the responsible, decision-making body. The Steering Board also decides on memberships and services offered.
The chairperson of the Steering Board is elected for a period of two years. The current chairperson is Prof Dr Yağız Üresin of the Center of Excellence for Clinical Research, Istanbul University.
C. Michael Gibson (MD): President, Baim Institute for Clinical Research, Boston, USA
Prof Dr Ian Wilkinson: Director of the Cambridge Clinical Trial Unit, Cambridge University Hospitals NHS Foundation Trust, United Kingdom
Dr phil. Britta Lang: Director of Clinical Trials Unit Freiburg, Albert-Ludwigs-University of Freiburg, Germany
Henry Yau, (MBA): Managing Director of Clinical Trials Centre, The Hong Kong University, China
Prof Dr Yagiz Üresin: Vice Director of the Center of Excellence for Clinical Research, Istanbul University, Turkey
Associate Prof Dr Tsutomu Nishimura: Clinical Research Center International Development Office, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Japan
Dr med. Christiane Blankenstein: Director of Münchner Studienzentrum, Hospital rechts der Isar, Technical University of Munich, Germany
Prof Dr Rongxing Gan: President and CEO of Shanghai Clinical Research Center, China
Damien Hong, Chief Operating Officer of Singapore Clinical Research Institute, Singapore
Prof Dr med. Gabriela Senti, Head of Clinical Trials Center Zurich, University Hospital Zurich, Switzerland
The ICN operates as much as possible on a decentralized basis. A core team manages common operations and processes.
Currently, ICN represents network without a legal entity. However, the Steering Board, as the highest decision making body of the ICN, will pursue adherence to agreed strategies, principles and standards.
With the current informal legal status of ICN, there are no financial obligations of members to the ICN organization or its leadership. Payable services will be contracted and settled bilaterally between the providing and the consuming partners.
Dr Fabian Tay, Dr María de Medina Redondo and Dr Anja Eskat: Clinical Trials Center Zurich, University Hospital Zurich, Switzerland
Please contact us via: firstname.lastname@example.org